A detailed history of Pluribus Labs, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Pluribus Labs, LLC holds 5,499 shares of MDT stock, worth $445,583. This represents 0.9% of its overall portfolio holdings.

Number of Shares
5,499
Previous 1,975 178.43%
Holding current value
$445,583
Previous $219,000 125.57%
% of portfolio
0.9%
Previous 0.87%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$87.4 - $113.09 $307,997 - $398,529
3,524 Added 178.43%
5,499 $494,000
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $198,645 - $221,950
1,975 New
1,975 $219,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Pluribus Labs, LLC Portfolio

Follow Pluribus Labs, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pluribus Labs, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pluribus Labs, LLC with notifications on news.